J

Jodha Tishon | Toronto, Canada

Research site

(Unclaimed)

Location

1033 Bay Street, Toronto, Ontario, Canada

Site insights

Top conditions

Top treatments

Daridorexant

TAK-994

ACT-541468

E2086

Atomoxetine

HBS-301

FT218

Solriamfetol

Aripiprazole

Aroxybutynin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

This is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled clinical study to assess the efficacy and safety of HBS-...

Enrolling

Cataplexy

EDS

Drug: HBS-301

Other: Placebo

A Study of Pitolisant in Patients With Prader-Willi Syndrome

This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, global clinical study to assess the efficacy and safety of pitolisant i...

Enrolling

Prader-Willi Syndrome

Other: Placebo tablet

Drug: Pitolisant tablet

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only

OSA

Drug: Aroxybutynin and Atomoxetine